 determine level tumor marker pyruvate kinase dimer (M2-PK) feces patients colorectal cancer benign polyps, well individuals chronic inflammatory bowel diseases. Fecal M2-PK determination could outlined highly reliable non-invasive approach diagnosis colorectal carcinoma. establishing elevated values patients chronic inflammatory bowel diseases decreases specificity M2-PK tumor marker. However, compromise essential clinical significance, precise diagnosis diseases imposes obligatory performance colonoscopy.